Company intelligence / Profile preview

Ergon Pharmaceuticals

Unknown††, Dhaka*?, Bangladeshergonbd.info ↗

Ownership: Private
Employees: ~65
Development stage: Commercial

Overview

Ergon Pharmaceuticals operates as a producer of Ayurvedic/herbal medicines with a broad commercial product line targeting common chronic and acute conditions. A separate US-based entity appears to be engaged in preclinical/translational research into B-cell metabolism as therapeutic targets for cancer and autoimmune diseases.

Therapeutic areas: Men's HealthMetabolic DisordersPulmonologyEndocrinologyRheumatologyGastroenterologyCardiovascularInfectious Diseases
Modalities: Herbal/Ayurvedic formulationsSmall molecules (inferred from drug pipeline context for LLC entity)
Industry: Biotech

Drug pipeline

15 assets

ERG344

Preclinical

14 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Ergon Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ergon Pharmaceuticals.

Explore the full profile